Irinotel Injection (Irinotecan) | Used in Cancer Treatment and Chemotherapy

Precaution

Low Blood Cell Counts
Irinotel Injection can reduce white blood cells, red blood cells, and platelets. Regular blood tests may be required during treatment. Report fever, unusual bleeding, bruising, or signs of infection promptly.

Diarrhea and Dehydration
Irinotecan can cause early or delayed diarrhea, which may sometimes become severe. Maintain adequate fluid intake as advised and promptly report persistent or severe diarrhea, especially if accompanied by weakness or reduced urination.

Liver-Related Conditions
People with liver problems should inform their healthcare professional before receiving Irinotel Injection. Liver function may affect how irinotecan is processed and may influence treatment decisions.

Severe Infection Risk
Reduced white blood cell counts can increase susceptibility to infections. Seek prompt medical attention for fever, chills, sore throat, or other signs of infection during treatment.

Lung-Related Symptoms
Inform the treating healthcare professional if you develop new or worsening breathing difficulties, persistent cough, or chest discomfort during treatment.

Pregnancy and Fertility
Irinotecan may harm an unborn baby. Inform the healthcare professional if you are pregnant, planning pregnancy, or could become pregnant. Appropriate contraception may be recommended during treatment.

Breastfeeding
Breastfeeding is generally not recommended during treatment with irinotecan because the medicine may pass into breast milk and could potentially affect the infant. Discuss appropriate guidance with the treating healthcare professional.

Previous Chemotherapy or Radiation
Tell the healthcare team about previous chemotherapy, radiation treatment, or other cancer therapies. Previous treatments may affect blood counts and the choice or timing of irinotecan treatment.

Close Medical Monitoring
Irinotel Injection should be administered under the supervision of a qualified healthcare professional. Follow the recommended blood tests, treatment appointments, and monitoring schedule throughout therapy.

Usage

Follow the Recommended Treatment Schedule

Irinotel Injection is administered according to the chemotherapy schedule determined by the treating healthcare professional. The dose and timing depend on the type of cancer, treatment regimen, and individual treatment factors.

Administered by Intravenous Infusion

Irinotel Injection is given into a vein through intravenous infusion by a qualified healthcare professional. It should not be self-administered.

Follow the Complete Treatment Plan

Irinotecan is generally given as part of a planned chemotherapy regimen. Follow the recommended treatment schedule and attend scheduled appointments to support consistent treatment.

Maintain Adequate Hydration

Diarrhea and vomiting can occur during irinotecan treatment and may contribute to fluid loss. Maintaining adequate fluid intake, as advised by the healthcare team, can help reduce the risk of dehydration.

Report Severe Diarrhea Promptly

Irinotecan can cause early or delayed diarrhea, which may sometimes become severe. Inform the treating healthcare professional promptly if diarrhea is persistent, severe, or associated with signs of dehydration.

Attend Recommended Monitoring

Blood counts and other health parameters may be monitored during treatment. Regular monitoring helps the healthcare team assess response to treatment and manage potential chemotherapy-related effects.

Uses

Colorectal Cancer Treatment

Irinotel Injection is used as part of chemotherapy regimens for certain types of colorectal cancer, including advanced or metastatic disease.

Combination Chemotherapy

Irinotecan may be combined with other anticancer medicines as part of established chemotherapy regimens. The combination depends on the cancer type and treatment plan.

Slowing Cancer Cell Growth

Irinotecan works by inhibiting topoisomerase I, an enzyme involved in DNA replication. This interferes with the growth and multiplication of rapidly dividing cancer cells.

Treatment of Advanced Cancer

Irinotel Injection may be included in treatment plans for certain advanced cancers when systemic chemotherapy is indicated.

Supporting Cancer Treatment

Irinotecan may form part of a broader cancer treatment strategy, either alone or alongside other anticancer medicines, according to the treatment regimen selected by the oncology team.

Management of Certain Cancer Conditions

The specific use, dose, and treatment schedule of Irinotel Injection depend on the type and stage of cancer, previous treatments, and the individual's overall treatment plan.

Side Effects

Diarrhea

Diarrhea is a common side effect of irinotecan and may sometimes become severe. Maintain adequate fluid intake and inform a healthcare professional if diarrhea is persistent, severe, or accompanied by weakness or dehydration.

Nausea and Vomiting

Irinotel Injection may cause nausea or vomiting during treatment. Antiemetic medicines may be used as part of the treatment plan to help manage these symptoms.

Weakness and Tiredness

Some people may experience fatigue, weakness, or reduced energy during chemotherapy with irinotecan. Adequate rest and appropriate supportive care may help manage these effects.

Loss of Appetite

Reduced appetite may occur during treatment. Maintaining adequate nutrition and fluid intake is important, particularly when appetite remains low for an extended period.

Hair Loss

Temporary hair loss or thinning may occur with irinotecan treatment. Hair generally begins to grow back after chemotherapy is completed, although the timing can vary.

Low Blood Cell Counts

Irinotecan can reduce blood cell counts, including white blood cells, red blood cells, and platelets. This may increase the risk of infections, anemia, or bleeding and may require regular blood count monitoring.

Fever or Infection

A decrease in white blood cells can make infections more likely. Fever, chills, sore throat, or other signs of infection should be reported promptly to a healthcare professional, particularly during chemotherapy.

FAQs

What Is Irinotel Injection?

Irinotel Injection contains irinotecan, an active ingredient used as part of chemotherapy treatment for certain types of cancer, particularly colorectal cancer.

What Is Irinotel Injection Used For?

It is generally used in chemotherapy regimens for certain colorectal cancers and other cancer conditions where irinotecan is included as part of the treatment plan.

How Does Irinotel Injection Work?

Irinotecan inhibits an enzyme called topoisomerase I, which is involved in DNA replication. This interferes with the ability of rapidly dividing cancer cells to multiply.

How Is Irinotel Injection Given?

Irinotel Injection is administered through intravenous infusion by a qualified healthcare professional. The dose and treatment schedule depend on the cancer type and chemotherapy regimen.

Can Irinotel Injection Cause Diarrhea?

Yes, diarrhea is a common effect of irinotecan and may occur shortly after treatment or later. Severe or persistent diarrhea should be reported promptly to the treating healthcare team.

Can Irinotel Injection Cause Low Blood Cell Counts?

Yes, irinotecan can reduce white blood cells, red blood cells, and platelets. Regular blood tests may be performed to monitor blood cell counts during treatment.

Can Irinotel Injection Cause Hair Loss?

Temporary hair loss or hair thinning may occur during irinotecan treatment. Hair growth generally resumes after chemotherapy, although recovery varies between individuals.

What Should I Do If I Develop Fever During Treatment?

Fever during chemotherapy can sometimes indicate an infection, particularly when white blood cell counts are low. Contact your treating healthcare professional promptly if you develop fever, chills, or other signs of infection.

Interactions

Medicines That Affect Liver Enzymes

Medicines that increase or decrease the activity of liver enzymes involved in irinotecan metabolism may alter its effects or increase the risk of side effects. Inform the treating healthcare professional about all medicines being used.

Anticonvulsant Medicines

Certain medicines used to control seizures, including enzyme-inducing anticonvulsants, may affect how irinotecan is processed in the body and can potentially alter its effectiveness. Your healthcare team should be informed if you take these medicines.

Antifungal Medicines

Some antifungal medicines can affect enzymes responsible for metabolizing irinotecan. This may change irinotecan exposure and increase the likelihood of adverse effects.

Certain Antibiotics

Some antibiotics may interfere with the metabolism of irinotecan or affect blood cell counts and gastrointestinal effects. Inform your healthcare professional about any antibiotics you are taking or have recently taken.

Medicines Affecting Blood Cell Counts

Medicines that can lower blood cell counts may increase the risk of neutropenia, anemia, or thrombocytopenia when used with irinotecan. Blood counts may require closer monitoring during combined treatment.

Medicines That Increase Diarrhea Risk

Other medicines that can cause diarrhea may worsen gastrointestinal effects during irinotecan treatment. Severe diarrhea should be reported promptly to the treating healthcare team.

Other Anticancer Medicines

Irinotel Injection may be used with other chemotherapy or anticancer medicines as part of combination treatment. The healthcare team considers potential interactions when selecting and scheduling these medicines.

All Regular Medicines and Supplements

Tell your oncologist or healthcare professional about all prescription medicines, over-the-counter products, vitamins, and supplements you use. This helps identify potential interactions and supports safe chemotherapy management.